Drug Patents owned by Accord

1. Drug name - CAMCEVI KIT

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10646572 ACCORD Pharmaceutical compositions with enhanced stability Jan, 2027

(4 years from now)

US9572857 ACCORD Pharmaceutical compositions with enhanced stability Jan, 2027

(4 years from now)

US9744207 ACCORD Pharmaceutical compositions with enhanced stability Jan, 2027

(4 years from now)

Drugs and Companies using LEUPROLIDE MESYLATE ingredient

Treatment: NA

Dosage: EMULSION;SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
EQ 42MG BASE EMULSION;SUBCUTANEOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.